Safety and efficacy of cabozantinib for patients with advanced hepatocellular carcinoma who advanced to Child–Pugh B liver function at study week 8: a retrospective analysis of the CELESTIAL randomised controlled trial

Peer Review reports

Original Submission
22 Sep 2021	Submitted	Original manuscript
Resubmission - Version 2
	Submitted	Manuscript version 2
2 Dec 2021	Reviewed	Reviewer Report - Kazuto Tajiri
14 Dec 2021	Reviewed	Reviewer Report
3 Mar 2022	Author responded	Author comments - Anthony B. El-Khoueiry
Resubmission - Version 3
3 Mar 2022	Submitted	Manuscript version 3
10 Mar 2022	Author responded	Author comments - Anthony B. El-Khoueiry
Resubmission - Version 4
10 Mar 2022	Submitted	Manuscript version 4
13 Mar 2022	Reviewed	Reviewer Report - Kazuto Tajiri
Resubmission - Version 5
	Submitted	Manuscript version 5
Publishing
16 Mar 2022	Editorially accepted
9 Apr 2022	Article published	10.1186/s12885-022-09453-z

Back to article page